Sprache: Englisch
Verlag: Cambridge University Press, 1998
ISBN 10: 0521473217 ISBN 13: 9780521473217
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 206,58
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Cambridge University Press, 1998
ISBN 10: 0521473217 ISBN 13: 9780521473217
Anbieter: Kennys Bookstore, Olney, MD, USA
EUR 291,70
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. International authorities review the mechanisms and clinical implications of drug resistance in cancer. Series: Cancer: Clinical Science in Practice. Num Pages: 340 pages, 35 b/w illus. 32 tables. BIC Classification: MJCL2. Category: (P) Professional & Vocational. Dimension: 228 x 152 x 22. Weight in Grams: 675. . 1998. hardcover. . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Cambridge University Press, 1998
ISBN 10: 0521473217 ISBN 13: 9780521473217
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 292,55
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 323 pages. 9.25x6.25x0.75 inches. In Stock.
Sprache: Englisch
Verlag: Cambridge University Press, 1998
ISBN 10: 0521473217 ISBN 13: 9780521473217
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The development of drug-resistant cancers is considered to be the most significant obstacle to the cure of cancer today. Nearly half of all patients with cancer suffer from tumours that are intrinsically resistant to chemotherapy, and most of the remaining half develop drug resistance during the course of their treatment. This book reviews the mechanisms and clinical implications of drug resistance in cancer with unrivalled authority. Chapters cover topics of current clinical concern, including multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support. The authors are among the leading clinicians and investigators in the field. These authoritative volumes in this series are intended for a wide audience of clinicians and researchers with an interest in the applications of biomedical science to the understanding and management of cancer.